Other
Wound Infection
0
Pipeline Programs↗
0
Active Trials↗
2
Companies Involved↗
Wound Infection is an early-stage landscape with 0 programs across 2 companies. The most active players are Precisio Biotix Therapeutics, Inc., MolecuLight Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed11 · 79%
Unknown status3 · 21%
Clinical Trials
Trial Activity
14 trials
Reduction of Postoperative Wound Infections by Antiseptica?
Completed·—·Phase 3·NCT04055233·456 enrolled
Wound Infections Following Implant Removal
Completed·—·Phase 4·NCT02225821·500 enrolled
Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection
Unknown status·—·Phase 3·NCT05021315·800 enrolled
To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates
Unknown status·—·Phase 4·NCT04917627·500 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)